- Home
- COYA vs INFU Comparison
COYA vs INFU Comparison
Compare COYA & INFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COYA
- INFU
- Stock Information
- Founded
- COYA 2020
- INFU 2005
- Country
- COYA United States
- INFU United States
- Employees
- COYA N/A
- INFU N/A
- Industry
- COYA Biotechnology: Pharmaceutical Preparations
- INFU Medical/Dental Instruments
- Sector
- COYA Health Care
- INFU Health Care
- Exchange
- COYA Nasdaq
- INFU Nasdaq
- Market Cap
- COYA 103.2M
- INFU 104.4M
- IPO Year
- COYA 2022
- INFU N/A
- Fundamental
- Price
- COYA $5.93
- INFU $6.16
- Analyst Decision
- COYA Strong Buy
- INFU
- Analyst Count
- COYA 4
- INFU 0
- Target Price
- COYA $17.00
- INFU N/A
- AVG Volume (30 Days)
- COYA 66.8K
- INFU 143.3K
- Earning Date
- COYA 05-13-2025
- INFU 05-08-2025
- Dividend Yield
- COYA N/A
- INFU N/A
- EPS Growth
- COYA N/A
- INFU 3654.89
- EPS
- COYA N/A
- INFU 0.15
- Revenue
- COYA $3,685,107.00
- INFU $137,582,000.00
- Revenue This Year
- COYA $94.45
- INFU $11.08
- Revenue Next Year
- COYA N/A
- INFU $8.02
- P/E Ratio
- COYA N/A
- INFU $41.59
- Revenue Growth
- COYA N/A
- INFU 7.98
- 52 Week Low
- COYA $4.65
- INFU $4.61
- 52 Week High
- COYA $10.24
- INFU $9.97
- Technical
- Relative Strength Index (RSI)
- COYA 48.29
- INFU 71.00
- Support Level
- COYA $5.63
- INFU $5.27
- Resistance Level
- COYA $6.53
- INFU $5.61
- Average True Range (ATR)
- COYA 0.46
- INFU 0.24
- MACD
- COYA -0.03
- INFU 0.18
- Stochastic Oscillator
- COYA 29.70
- INFU 94.92
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
About INFU InfuSystems Holdings Inc.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-reportable segment. The first is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second, Device Solutions, supports the Patient Services platform and leverages service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Majority from Patient.